Bayesian Capital Management, LP Cooper Companies, Inc. Transaction History

Bayesian Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$323.56 - $373.36 $635,471 - $733,279	1,964 New	1,964 $733,000
Q3 2022 Nov 14, 2022	BUY	$263.81 - $337.27 $299,951 - $383,475	1,137 New	1,137 $300,000
Q2 2022 Aug 15, 2022	SELL	$301.4 - $428.42 $483,445 - $687,185	-1,604 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$379.46 - $424.54 $608,653 - $680,962	1,604 New	1,604 $670,000
Q3 2020 Nov 12, 2020	SELL	$280.08 - $347.78 $204,178 - $253,531	-729 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$270.93 - $320.3 $197,507 - $233,498	729 New	729 $207,000
Q3 2019 Nov 13, 2019	SELL	$294.25 - $341.49 $324,557 - $376,663	-1,103 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$279.29 - $336.89 $308,056 - $371,589	1,103 New	1,103 $372,000
Q3 2018 Nov 14, 2018	SELL	$236.3 - $277.15 $1.21 Million - $1.42 Million	-5,128 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$217.98 - $237.23 $1.12 Million - $1.22 Million	5,128 New	5,128 $1.21 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.